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Natural killer (NK) cells can derive from the same precursors as B andT cells, however, to
achieve lineage speciﬁcity, several transcription factors need to be activated or annulled.
While a few important transcription factors have been identiﬁed for NK genesis the
mechanisms of how this is achieved is far from resolved. Adding to the complexity of
this, NK cells are found and potentially develop in diverse locations in vivo and it remains to
be addressed if a common NK cell precursor seeds diverse niches and how transcription
factors may differentially regulate NK cell commitment in distinct microenvironments. Here
we will summarize some recent ﬁndings in NK cell commitment and discuss how a NK cell
transcriptional network might be organized, while addressing some misconceptions and
anomalies along the way.
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GENERAL INTRODUCTION OF NK CELLS
Natural killer (NK) cell research is experiencing somewhat of a
revolution. Gone are the days when NK cells could be described as
a homogenous innate lymphoid cells (ILC) population producing
inﬂammatory cytokines and cytotoxic granules when encounter-
ing cells with missing/altered self-MHC-I expression. Now NK
cells can be viewed as a “jack-of-all-trades”; a diverse lineage
implicated in innate and adaptive immunity where speciﬁcation
to pathogen response is shaped by parameters such as matu-
ration state, anatomical location, interaction with self-MHC-I,
history of inﬂammation or pathogen exposure, receptor expres-
sion, growth factor responsiveness, and survival status. Despite
these advances in our understanding of effector and regulatory
functions of NKcells,many key questions surrounding their origin
and development remain.
Natural killer cells are ILCs and like B and T cells, NK cells
undergo an ordered and rather linear maturation process. How-
ever, unlike B and T cells that take longer to develop and become
fully capable of performing their effector functions, mature NK
cells emerge early and are rapidly activated upon detection of
pathogens (Huntington et al., 2007b). So what is unique about
the genetic programing of the NK cell lineage that sets them
apart from other lymphocytes? Of course, we must generalize a
little when discussing NK cells, as this population appears pro-
foundly more diverse than we ﬁrst envisaged (Huntington et al.,
2007b). NK cells represent a considerable fraction of mononu-
clear cells in human peripheral blood and while this fraction
is somewhat less in mice, NK cells can be found in all sec-
ondary lymphoid organs and associated lymphoid tissues in both
species (Huntington et al., 2007b). The origin of conventional
NK (cNK) cells is the bone marrow (Haller et al., 1977). At
this site, lymphoid progenitors capable of differentiating into
B, T, and NK cells, either via environmental cues or stochas-
tic gene expression, are committed toward one of these lineages
(Kondo et al., 1997). This process involves large-scale genetic
changes within the committing cells, ultimately activating genes
of one lineage while repressing genes of other lineages. B and
T lymphoid commitment is better understood than that of NK
cells and a set of key genetic regulators of B and T cells fate
have been identiﬁed and their expression consigns progeny to
that lineage (Warren and Rothenberg, 2003). In the case of B
cells, Pax5 represses non-B cell genes while activating B cell-
speciﬁc genes while E2A/Notch1/TCF7/bcl11b perform similar
roles in T cells (Nutt et al., 2001; Warren and Rothenberg, 2003).
However, a “master regulator” of the NK cell lineage remains
elusive. Here we discuss the recent advances that have been
made in the ﬁeld of transcriptional regulation of NK cell lineage
commitment.
NK CELL DEVELOPMENT
Natural killer cells can be grouped based on their organ of devel-
opment: bone marrow-derived or cNK cells, thymic NK cells, fetal
liver NK cells, and potentially intestinal NK cells.
cNK CELL DEVELOPMENT
Conventional NK cells constitute the major and best characterized
population of NK cells and are formed from lymphoid progenitors
in the bone marrow (Figure 1). To search for the earliest commit-
tedNK cell progenitor (NKP),we recentlymade use of an inhibitor
of DNA binding 2 (ID2)-GFP reporter mouse where GFP was
expressed in all cNK cells under the control of the ID2 promoter
(Carotta et al., 2011; Jackson et al., 2011). Analysis of the bone
marrow revealed that common lymphoid progenitors (CLPs) were
GFP−, however, a small population of GFP+ cells was detected in
the FLT3− CLP fraction. These GFP+ cells were further charac-
terized Lin-ID2+Sca1+CD127+CD117lowCD135−CD122− and
efﬁciently differentiated into NK cells in vitro while having lost
T and B cell potential (Carotta et al., 2011). A similar popu-
lation was identiﬁed amongst the Lin-Sca1+CD117− fraction
and while we termed the CD117low population pre-pro A and
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FIGURE 1 | Schematic of murine conventional NK cell development with the cell surface phenotype and required genes at each stage of
development. Line width is proportional to expression level.
the CD117− population pre-pro B NK cells, the relationship
between the two subsets remains is unresolved. Prior to the
generation of ID2-GFP mice, the earliest committed NKP was
identiﬁed through the expression of the IL-2 receptor β chain
and the absence of lineage markers including the pan-NK cell
markers NK1.1 and CD49b (DX5; Rosmaraki et al., 2001). How-
ever, this population was heterogeneous with only a minority of
cells being NK cell committed. We puriﬁed the NKP within the
lin−CD122+NK1.1−CD49b− population using ID2-GFP mice
and found that NKP cells could be divided into ID2-GFP express-
ing cells andnon-expressing cells (Carotta et al., 2011).When these
populations were subjected to in vitro differentiation conditions
that favor B, T, or NK cell development, only ID2 express-
ing NKP cells contained NK cell committed progenitor cells.
More recently, Fathman et al. (2011) identiﬁed similar progeni-
tors to our pre-pro NK and ID2+NKP using the surface marker
CD244 and CD27. Lin−CD27+CD244+CD127+CD117low bone
marrow progenitors were divided into CD135+CD122−CLP,
CD135−CD122− pre NK, and CD135−CD122+ NKP, with the
latter named rNKP. In vivo and in vitro assays revealed that,
like pre-pro NK and ID2+ NKP, pre NK and rNKP were com-
mitted to the NK cell lineage (Fathman et al., 2011). Since
pre-pro NK and pre NK cells show high similarity, as do
Id2+NKP and rNKP, it is currently unclear if these popula-
tions are identical or if they constitute distinct stages of NK
cell commitment. In light of the recent ﬁndings, a differentia-
tion model is proposed in which CLPs give rise to pre-pro NK
cells, then ID2+NKP which in turn give rise to immature and
ultimately mature NK cells and propose to unify the nomencla-
ture of early NK development into pre-pro NK cells and rNKP
(Figure 1).
An open question in the ﬁeld of innate immunity to date
is the existence of a hypothetical progenitor, the common
innate lymphocyte progenitor (CILP). CILP are proposed to be
the bone marrow precursor of cNK, RORγt-dependent ILCs
and Gata3-dependent ILC (also known as ILC2 or nuocytes).
To date, pre-pro NK cells have not been tested for ILC or
ILC2 potential and it will be of interest if the pre-pro NK
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population is indeed the earliest NKP or represent the proposed
CILP.
Transcriptional regulation of the commitment of NK cell from
lymphoid progenitors
Several key transcription factors have been identiﬁed that regu-
late the commitment of lymphoid progenitors into T or B cells
(Nutt and Kee, 2007). Surprisingly, only a few transcription fac-
tors so far have been discovered to regulate the earliest steps that
commit lymphoid progenitors to the NK cell lineage. Even less
understood is how these factors implement the NK cell-speciﬁc
transcriptional network. Due to the heterogeneous nature of
the initially discovered lin−CD122+CD49b−NK1.1− NKP, most
NK cell commitment factors are described to act after the NKP
cell stage (Yokota et al., 1999; Boos et al., 2007; Gascoyne et al.,
2009; Kamizono et al., 2009). It is therefore possible that the
described phenotype has been masked by the impurity of NKP
population and re-investigation of the phenotype of mice deﬁ-
cient in these factors using the developmental scheme outlined
in Figure 1 is warranted. Support for this hypothesis comes
from a recent study that reinvestigated early NK cell develop-
ment in Ets-1−/− mice which indeed found that Ets-1 deﬁciency
already affects the formation of the earliest NK cells precursors
(Ramirez et al., 2012). Here we review the transcription factors
that have been found to function in the regulation of early NK cell
development.
Inhibitor of DNA binding 2 Inhibitor of DNA binding 2 is
expressed in many different hematopoietic tissues (Jackson et al.,
2011). Mice deﬁcient in Id2 lack peripheral lymphoid tissues such
as Peyer’s patch and lymph nodes, most cNK cells, dendritic cells,
and T cells (Yokota et al., 1999; Boos et al., 2007). ID proteins
lack a DNA-binding region and are though to function solely by
dimerizationwith other transcription factorsmediating inhibition
in a dominant negative manner. Regulation of lineage develop-
ment is mediated by the interaction of basic helix-loop-proteins
of the E-box binding family (E2A, HEB, E2-2) with ID proteins
(Quong et al., 2002). Of the four ID family members, ID2 and
ID3 are the main proteins involved in lymphoid development and
control the activity of E-proteins (Quong et al., 2002). Previous
work has shown that Id2 is required for cNK cell development,
with a strong decrease in bone marrow resident immature NK
(iNK) cells. Whether ID2 acts even earlier and determines NK cell
commitment from CLPs is not clear due to the ill deﬁned early
NKP as well as the formation of the recently identiﬁed pre-pro
NK cells in the absence of ID2 has not been analyzed yet (Yokota
et al., 1999; Boos et al., 2007). Given the fact that the earliest NK
cell precursor, pre-pro NK cells, already express high levels of
ID2 (Carotta et al., 2011), determining the formation of the ear-
liest NKP in the absence of ID2 will be of interest. Inhibition
of E-protein target genes is required for the propagation of NK
cells past this NKP/immature stage (Boos et al., 2007). Further-
more, if E2A is also deleted in Id2−/− NK cells (E2A−/−Id2−/−)
NK cell development in the bone marrow appears to return to
normality (Boos et al., 2007). Peripheral mature NK cells are still
reduced in E2A−/−Id2−/− mice to the level observed in Id2−/−
mice suggesting that expression of E-protein target genes con-
tributes to the block in Id2−/− NK cell development in the
bone marrow, but Id2 itself is still required to permit normal
NK cell maturation (Boos et al., 2007). It is difﬁcult to specu-
late which E2A regulated genes might be involved in limiting NK
cell commitment since our knowledge of E-protein target genes is
incomplete.
Nuclear factor IL-3 (E4BP4) Nuclear factor IL-3 (NFIL3), also
known as E4-binding protein 4 (E4BP4), belongs to the mam-
malian basic leucine zipper transcription factor family and func-
tions in a variety of cellular processes such as in the transcriptional
control of circadian clock, neural development, and survival to
mention a few (Male et al., 2012). Within the hematopoietic sys-
tem, NFIL3 functions in the macrophage, B, T,NKT, and dendritic
cell lineages. Within the NK cell lineage, loss of NFIL3 results
in a strong reduction of mature cNK cells (Gascoyne et al., 2009;
Kamizono et al., 2009). As for Id2−/− mice, NKP were still present
in Nﬁl3−/− mice. Given the severity of the KO phenotype and
because NFIL3 is already expressed in lineage negative bone mar-
row cells as well as NKP (Gascoyne et al., 2009), re-examination of
the effect of NFIL3 within the earliest NK cell populations will
be informative on whether NFIL3 is a key factor that induces
NK cell commitment or functions at a later stage, potentially
downstream of Ets-1 (Ramirez et al., 2012), to implement NK
cell fate.
Mechanistically it has been proposed that NFIL3 functions
upstream of ID2, as ID2 expression was reduced in Nﬁl3−/− bone
marrow progenitors and enforced expression of ID2 in NFIL3
deﬁcient NK cells could partially rescue NK cell development
(Gascoyne et al., 2009). However, it is currently not known if the
potential regulation of ID2 by NFIL3 is direct or indirect. Further-
more, loss of NFIL3 expression resulted inonly approximately 30%
reduction of ID2 expression (Gascoyne et al., 2009). As Id2 het-
erozygous mice have normal NK cell numbers it remains unclear
how important the proposed regulation of Id2 by NFIL3 is for NK
cell development (Yokota et al., 1999; Boos et al., 2007).
NFIL3 was also proposed to regulate IL-15 signaling as NFIL3-
deﬁcient bone marrow progenitor could not respond to IL-15
stimulation and ectopic NFIL3 expression allowed some NK cell
development in the absence of IL15 signaling (Gascoyne et al.,
2009). Interestingly, NKT cells, which express NFIL3 and also
depend on IL-15 signaling for development and homeostasis,
were not found to be affected in NFIL3-deﬁcient mice (Gas-
coyne et al., 2009; Kamizono et al., 2009), suggesting NFIL3
is one of the key regulators of NK cell development, how-
ever, much further work is needed to when and how NFIL3
functions.
Ikaros (IKZF1) Ikaros is the founding member of a small fam-
ily of Krüppel-type zinc ﬁnger transcription factors. Ikaros is
expressed as early as in the hematopoietic stem cell and is widely
expressed in lymphoid and myeloid progenitor cells (Yoshida et al.,
2006). Several Ikaros mutant mouse models have been generated
which revealed an essential role of Ikaros in lymphoid develop-
ment and homeostasis. Ikaros null mice lack all B, T, and NK cells.
NK cells are virtually absent in the spleen of Ikaros-deﬁcient mice
and Ikaros-deﬁcient progenitors were not able to differentiate into
NK cells in vitro (Georgopoulos et al., 1992, 1994; Wang et al.,
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1996; Morgan et al., 1997; Payne et al., 2003). Because Ikaros is
expressed in NK cells and Ikaros null mice lack NK cells, it is cur-
rently widely postulated that Ikaros is an essential regulator of NK
cell commitment (Georgopoulos et al., 1997; Hesslein and Lanier,
2011). However, it cannot be excluded that the block of lymphoid
development in Ikaros null mice might be as early as at the CLP
stage (Yoshida et al., 2006) as Ikaros regulates cytokine receptors
that are important for the generation of CLPs such as CD135 and
Ikaros null mice lack or have strongly reduced numbers of B, T,
and NK cells. The generation of mice that allow the conditional
deletion of Ikaros at or after the CLP stage as well as in committed
NK cells would reveal the exact stages in which Ikaros functions in
NK cell development.
PU.1 (Sfp1) PU.1 belongs to the Ets transcription factor family.
Like Ikaros, PU.1 is expressed at high levels in HSC and contin-
ues to be expressed and function in many hematopoietic lineages
(Nutt et al., 2005). Pu.1−/− mice die in late gestation or within the
ﬁrst days after birth and lack all lymphocytes as well as granulo-
cytes and macrophages. Conditional deletion of Pu.1 in adult HSC
resulted in the absence of lymphoid cells as well as macrophages,
while granulocytes were expanded. PU.1 has been shown to have
a critical role in the development of CLP in part by regulating
receptors essential for proliferation, survival, and differentiation
of CLP (Scott et al., 1994, 1997; McKercher et al., 1996; Spain et al.,
1999; Carotta et al., 2010b). The development of mature B, T, and
NK cells following engraftment of Pu.1−/− fetal liver into alym-
phoid (Rag2−/−gC−/−) mice is blocked (Colucci et al., 2001).
Because PU.1 protein was detected in the lysates of IL-2 expanded
NK cells and it was concluded that PU.1 was required for nor-
mal NK cell genesis, although this requirement is less stringent
to that of B and T cell development (Colucci et al., 2001). How-
ever, re-investigation of PU.1 expression in hematopoietic cells at
a single cell level using a PU.1-GFP reporter mouse model revealed
no expression of PU.1 in pre-pro NK cells as well as mature NK
cells (Nutt et al., 2005; Carotta et al., 2010a). This is supported at
the mRNA level (Immgen; www.immgen.org). We repeated the
experimental condition of Colucci et al. (2001) by growing sorted
NK1.1+CD3− NK cells in recombinant IL-2 or IL-15 for 7 days,
however, failed to detect any PU.1-GFP expression (Figure 2). It
is possible that the small population of Pu.1−/− NK cells detected
in recipient mice are derived from a subset of PU.1-independent
CLPs, or they are the remnants of Pu.1−/− fetal liver NK cells or
progeny of Pu.1−/− fetal liver NKPs contained within the graft.
While Colucci et al. (2001) did not investigate this possibility, it
was recently shown that the E14.5 fetal liver contains a clear pop-
ulation of NKP and NK cells (Tang et al., 2012). E18.5 fetal NKPs
readily differentiated into mature NK cells in vitro whereas B, T,
and myeloid potential are absent (Tang et al., 2012). Lastly on
this issue, liver NK1.1+CD49b−TRAIL+ NK cells in Pu.1-GFP+
mice were also negative for PU.1 expression (Figure 2) and RNA
sequencingof CLPs andpre-proNKcells fromwild typebonemar-
row reveals that PU.1 expression is shut off upon commitment to
the NK cell lineage, with pre-pro NK cells and mature NK cells
having similarly negligible expression of PU.1 RNA (our unpub-
lished observations). PU.1 has been reported to directly regulate
the expression of the cytokine receptors Flt3 and IL7Rα, both of
which are expressed on CLPs (DeKoter et al., 2002; Carotta et al.,
2010a). Flt3/IL7Rα double deﬁcient mice show defective B, T, and
NK cell development (Vosshenrich et al., 2003) and it is thus likely
that PU.1 is not a speciﬁc regulator of NK cell development but
instead a key regulator of CLP development.
ETS-1 ETS-1 is the founding member of the Ets transcription
factor family. It is expressed in a variety of hematopoietic lin-
eages and Ets1-deﬁcient mice have defects in T, B, and NK cells.
However, Ets1−/− mice develop normal numbers of CLPs but do
have reduced pre-pro NK, rNKP, and mature NK cells, indicat-
ing that ETS-1 is a key regulator of early NK cell development
(Barton et al., 1998; Ramirez et al., 2012). A recent study found
that by comparing the gene expression of wild type mature and
residual Ets-1-deﬁcient NK cells as well as chromatin immune-
precipitation studies that ETS-1 potentially regulates early NK cell
commitment by directly regulating ID2 expression as well as T-bet,
an important transcription factor normal NK cell development
(Ramirez et al., 2012). Other potential ETS-1 target genes that
might explain the severe block in NK cell development include,
Jak3, an essential mediator of IL-15 receptor signaling (Park et al.,
1995; Aringer et al., 2003). However, a failure of Ets1-null NKP or
iNK cells to respond normally to IL-15 seems unlikely as mature
Ets1−/− NK cells appeared if anything hyper-responsive to IL-15
in vitro (Ramirez et al., 2012).
STAT5 The activation of STAT5 is an early signaling event fol-
lowing IL-15 binding the IL-15 receptor complex. IL-15 binding
results in Jak1/Jak3 activation and phosphorylation of STAT5 that
is recruited to phosphorylated IL-15 receptors via their SH2-
domain (O’Shea and Plenge, 2012). Phospho-STAT5 then form
dimers and translocate to the nucleus to initiate transcription of
target genes namely involved in cytokine signaling, cell cycle, and
survival (Malin et al., 2010; O’Shea and Plenge, 2012). There is
no direct evidence that STAT5 activates genes involved in NK cell
development such as Id2, Nﬁl3, Ets1, T-bet despite STAT5-null
mice having dramatically reduced NK cell numbers (Nakajima
et al., 1997; Imada et al., 1998). STAT5 is suggested to indirectly
regulate IL-2Rβ expression (Basham et al., 2008) and most evi-
dence would point to a block in IL-15 signaling as the cause
of the NK cell phenotype in Stat5-null mice (Nakajima et al.,
1997; Imada et al., 1998). Deletion of Stat5 uniquely in NK cells
using STAT5ﬂ/ﬂ mice bred to BAC NCR1-Cre mice resulted in
a speciﬁc reduction in peripheral NK cells by three- to ﬁvefold
compared to non-Cre expressing mice conﬁrming that STAT5 is
critical for the maintenance of mature NKp46+ NK cells in vivo
(Eckelhart et al., 2011).
THYMIC NK CELL DEVELOPMENT
Thymic NK cells differ from cNK cells in several aspects: while
cNK development depends on IL-15 and have high cytolytic and
cytokine secretion potential, thymic NK development depends
on IL-7 signaling, possess weak cytotoxicity but are strong pro-
ducers of interferon-gamma (IFN-γ), granulocyte–macrophage
colony-stimulating factor and tumor necrosis factor (Huntington
et al., 2007b). Several obvious differences in the molecular regula-
tion between thymic and cNK cell development exist. Firstly, high
expression of E-protein target genes would precede commitment
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FIGURE 2 | Analysis of PU.1-GFP expression in NK cells from PU.1 reporter mice. Intensity of PU.1-GFP levels in (A) spleen, (B) liver, and (C) in vitro
expanded splenic NK cells were determined by ﬂuorescence-activated cell sorter (FACS) and compared to B cells and macrophages from PU.1-GFP reporter
mice or NK cells from C57BL/6 mice.
to the NK cell lineage in the thymus as NK cells can be derived
from DN thymocytes expressing levels of ID2 and high levels of
E2A. This is not predicted to be the case in the bone marrow where
increasing expression of ID2 or E-proteins target genes are thought
to directly inﬂuence lymphoid fate with NK cells development
being synonymous with high ID2 and low E-protein target gene
expression. Furthermore, thymic NK cells have been proposed
to develop independently of ID2 (Boos et al., 2007). Intriguingly,
NK cells in periphery of Id2−/− mice also have higher expres-
sion of CD127 and lower levels of CD11b and CD43, a phenotype
reminiscent of thymic NK cells (Vosshenrich et al., 2006; Boos
et al., 2007).
GATA3
GATA3 expression was shown to be required for thymic NK
cell development using transfers of Gata-3 deﬁcient fetal liv-
ers into Rag2−/− mice (Vosshenrich et al., 2006). GATA3 is
highly expressed in DN2/DN3 thymocytes and required for T
cell progression past this stage (Ting et al., 1996; Hendriks et al.,
1999; Hosoya et al., 2009). Since thymic NK cells can be derived
from DN1/DN2 thymocytes (Li et al., 2010; Vargas et al., 2011)
the role for GATA3 in thymic NK cell generation could reﬂect
the importance of GATA3 in DN thymocyte homeostasis. In
contrast, cNK cells develop normally in the absence of GATA3
with a phenotype noted in IFN-γ production and liver homing
(Samson et al., 2003).
HUMAN THYMIC NK CELLS
IL-15 promotes the differentiation or expands committed progen-
itors from human CD34+CD1a− thymocytes in FTOCs (Schotte
et al., 2010) and while the phenotype of this progenitor is shared
by conventional HSCs, Notch signaling is present in this system,
conﬁrming murine studies that Notch is not detrimental to NK
lineage commitment (Carotta et al., 2006). Thymic CD34+CD1a−
cells express negligible levels of ID2 compared to thymic NK cells
and retroviral overexpression of ID2 greatly promoted NK cell
development in FTOCs at the expense of T cells. NK cells were not
generated when overexpressing ID2 in thymic CD34+CD1a− cells
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were cultured on OP9-DL1 with IL-7 and Flt-3L indicating IL-15
is essential for this process and that OP9 cells fail to deliver this.
While CD34+CD1a− thymocytes express higher levels of ID2 than
ID3, overexpression of ID3 in fetal liver progenitors yields a sim-
ilar phenotype with a T cell development block in favor of NK
cells (Heemskerk et al., 1997). The difference in requirement for
ID2 between human and mouse thymic NK cells may also explain
their phenotypic differences with mouse thymic NK cells unani-
mously expressing CD127 (Vosshenrich et al., 2006), whereas only
aminor fractionof NKcells in thehuman thymus expressesCD127
(Schotte et al., 2010).
FETAL LIVER NK CELL DEVELOPMENT
Natural killer cells develop and reside in the fetal liver before
birth in both man and mouse although their role at this
early stage of development is unclear (Phillips et al., 1992;
Takeda et al., 2005; Tang et al., 2012). Murine fetal NK cells
are present from E14 (Tang et al., 2012) and are predomi-
nantly NK1.1+CD49b−TRAIL+Mac-1−Ly49− and not depen-
dent on Eomes for their development, which contrasts adult cNK
cells being NK1.1+CD49b−TRAIL+Mac-1+Ly49+ and Eomes-
dependent (Gordon et al., 2012). NK1.1+CD49b−TRAIL+Mac-
1−Ly49− NK cells are maintained in the liver into adulthood,
however, the size of this population reduces over time as cNK cells
develop and represent the majority of the NK cell compartment
in the liver of adult mice (Takeda et al., 2005; Huntington et al.,
2007a). Evidence suggests that cNK cells can be derived from liver
NK1.1+CD49b−TRAIL+Mac-1−Ly49− NK cells following adop-
tive transfer (Takeda et al., 2005; Gordon et al., 2012), however, the
contribution of the fetal liverNK cells versus bonemarrowpre-pro
NK cells to the cNK cell pool in vivo remains to be examined.
The transcriptional requirement for fetal NK cell devel-
opment is also an area of uncertainty, although this pop-
ulation is dependent on γC signaling, because we do not
detect this population (NK1.1+CD49b−TRAIL+Mac-1−Ly49−)
in Rag2−/−γC−/− mice (Huntington et al., 2007a). Differential
transcription factor dependence of fetal versus cNK cell develop-
ment could also inﬂuence experiments where fetal liver transfers
are used as a source of HSCs. Indeed in the case of PU.1, we do
not know whether Pu.1−/− E14.5 fetal livers contain NK cells and
NKPs but the possibility cannot be ruled out. The layered immune
system theory also supports the idea that fetal and adult immune
cells of the same lineage have different gene regulation pathways
that dictate functional responses to pathogens such as tolerogenic
versus immunogenic in fetal and adult cells, respectively (Mold
and McCune, 2011, 2012). When transferred into Rag2−/−γC−/−
mice,NK1.1+CD49b−TRAIL+Mac-1−Ly49− NKcells gave rise to
NK cells resembling cNK cells (Gordon et al., 2012) and since we
know that immature and mature NK cells undergo homeostatic
expansion in Rag2−/−γC−/− mice (Huntington et al., 2007a), any
Pu.1−/− fetal liver derived NKP or NK cells could give rise to the
small number of NK cells reported in the Rag2−/−γC−/− mice by
Colucci et al. (2001) without having passed through the conven-
tion bone marrow pathway where PU.1 deletion appears to block
CLP development.
CONCLUDING REMARKS AND OPEN QUESTIONS
Several transcription factors have been identiﬁed to regulate the
development of lymphoid progenitors into NK cells. As indicated
above, for several of them it is still unclear at what develop-
mental stage they act. Re-examination of earliest steps of NK
cell development in these KO mice will be informative in which
order these transcription factors work and how they inﬂuence
NK lineage commitment and repress alternative lineage fates.
The future determination of target genes of these factors will
be of immense importance for our understanding of the tran-
scriptional network that regulates NK cell commitment. Most of
these transcription factors are not only expressed during the ear-
liest steps of NK cell development but continue to be expressed
during NK cell development. It will also be of interest to deter-
mine if these factors are also important regulators of NK cell
function.
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